[go: up one dir, main page]

RU96115219A - METHOD FOR TREATING PATIENTS WITH SUGAR DIABETES - Google Patents

METHOD FOR TREATING PATIENTS WITH SUGAR DIABETES

Info

Publication number
RU96115219A
RU96115219A RU96115219/14A RU96115219A RU96115219A RU 96115219 A RU96115219 A RU 96115219A RU 96115219/14 A RU96115219/14 A RU 96115219/14A RU 96115219 A RU96115219 A RU 96115219A RU 96115219 A RU96115219 A RU 96115219A
Authority
RU
Russia
Prior art keywords
treating patients
sugar diabetes
sugar
antioxidant
diabetes
Prior art date
Application number
RU96115219/14A
Other languages
Russian (ru)
Other versions
RU2134109C1 (en
Inventor
О.Е. Колесова
Т.Ю. Уханова
Л.Д. Смирнов
Г.И. Шапошникова
А.А. Маркин
Original Assignee
Российская медицинская академия последипломного образования МЗ и МП РФ
Filing date
Publication date
Application filed by Российская медицинская академия последипломного образования МЗ и МП РФ filed Critical Российская медицинская академия последипломного образования МЗ и МП РФ
Priority to RU96115219/14A priority Critical patent/RU2134109C1/en
Priority claimed from RU96115219/14A external-priority patent/RU2134109C1/en
Publication of RU96115219A publication Critical patent/RU96115219A/en
Application granted granted Critical
Publication of RU2134109C1 publication Critical patent/RU2134109C1/en

Links

Claims (1)

Способ лечения больных сахарным диабетом, включающий введение в организм больного инсулина и/или сахаропонижающего препарата и антиоксиданта, отличающийся тем, что в качестве антиоксиданта используют мексидол, который вводят внутримышечно и/или перорально один раз в день в дозе 100 - 200 мг в течение 5-7 дней, курс лечения повторяют через 3 - 4 месяца.A method of treating patients with diabetes mellitus, comprising administering insulin and / or a sugar-lowering drug and an antioxidant to the patient, characterized in that mexidol is used as an antioxidant, which is administered intramuscularly and / or orally once a day at a dose of 100-200 mg for 5 -7 days, the course of treatment is repeated after 3 to 4 months.
RU96115219/14A 1996-07-26 1996-07-26 Method of treatment of patients with diabetes mellitus RU2134109C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96115219/14A RU2134109C1 (en) 1996-07-26 1996-07-26 Method of treatment of patients with diabetes mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96115219/14A RU2134109C1 (en) 1996-07-26 1996-07-26 Method of treatment of patients with diabetes mellitus

Publications (2)

Publication Number Publication Date
RU96115219A true RU96115219A (en) 1998-10-27
RU2134109C1 RU2134109C1 (en) 1999-08-10

Family

ID=20183811

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96115219/14A RU2134109C1 (en) 1996-07-26 1996-07-26 Method of treatment of patients with diabetes mellitus

Country Status (1)

Country Link
RU (1) RU2134109C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2493841C1 (en) * 2012-10-09 2013-09-27 Станислав Анатольевич Кедик Synergetic preparation for treating cardiovascular diseases, diabetes mellitus and hepatobiliary diseases

Similar Documents

Publication Publication Date Title
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
KR950703951A (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC
MXPA03006217A (en) Spaced drug delivery system.
KR890012666A (en) Treatment of Kidney Disease
RU95101385A (en) Products containing g-csf and tnf-binding protein
KR950007848A (en) Treatment of Anxiety with (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide
KR970061244A (en) Pharmaceutical composition for treating dementia
WO2001012214A3 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
RU2001118854A (en) OPTICALLY ACTIVE DERIVATIVE OF Pyridyl-4H-1,2,4-Oxadiazine AND ITS APPLICATION FOR TREATMENT OF VASCULAR DISEASES
JPH01261334A (en) Medical preparation containing angiotensine invertase inhibitor as effective component and production thereof
EP0459377B1 (en) Use of E1 prostaglandin to cure male erectile inpotence
RU96115219A (en) METHOD FOR TREATING PATIENTS WITH SUGAR DIABETES
Beyer et al. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study
KR880004810A (en) Peptic Ulcer Treatment
Romano et al. Clinical effect of human-fibroblast-derived (Beta) interferon in treatment of adeno-virus epidemic keratoconjunctivitis and its complications
SE9101341D0 (en) NEW MEDICINAL USE
JPH0251405B2 (en)
RU2004243C1 (en) Method for treating psoriasis
RU98104284A (en) METHOD FOR CORRECTION OF INSULIN RESISTANCE
RU93021361A (en) METHOD OF TREATING EXTRAPYRAMID SYNDROME IN ACUTE HALOPERIDOL POISON
JPH05221856A (en) Injury cure-stimulating agent
SU1657189A1 (en) Method of correcting apatho-abulic states at schizophrenia
RU93007469A (en) A method for the treatment of inflammatory diseases of the maxillofacial region in patients with diabetes mellitus
KR890001558A (en) Zephyron and its pharmaceutically acceptable acid addition salts alleviate panic disorder
MD1469G2 (en) Method of treatment of the burn shock